Buscar
Mostrando ítems 1-2 de 2
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
(Impact Journals, 2017)
info:eu-repo/semantics/article,
The CHL1 gene encodes a cell-adhesion molecule proposed as being a putative
tumour-suppressor gene in breast cancer (BC). However, neither the underlying
molecular mechanisms nor the clinical value of CHL1 downregulation ...
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
(BioMed Central, 2017)
info:eu-repo/semantics/article,
Background: Cadherin-like protein 22 (CDH22) is a transmembrane glycoprotein involved in cell-cell adhesion and
metastasis. Its role in cancer is controversial because it has been described as being upregulated in ...